| NCT06447662 |
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. |
View |
| NCT06164691 |
Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer |
View |
| NCT00024362 |
BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery |
View |
| NCT03146962 |
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies |
View |
| NCT03165591 |
Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer |
View |
| NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
View |
| NCT06151262 |
A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer |
View |
| NCT00967291 |
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer |
View |
| NCT00154791 |
Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma |
View |
| NCT05431582 |
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors |
View |
| NCT05327582 |
An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC |
View |
| NCT02648282 |
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer |
View |
| NCT01525082 |
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors |
View |
| NCT00919282 |
Gemcitabine (GFF) in Patients With Pancreatic Cancer |
View |
| NCT05841420 |
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer |
View |
| NCT00059982 |
Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer |
View |
| NCT02910882 |
PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer |
View |
| NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
View |
| NCT05727020 |
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma |
View |
| NCT05095831 |
EUS Shear Wave for Solid Pancreatic Lesions. |
View |
| NCT01182831 |
Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas |
View |
| NCT06759740 |
An Exploratory Study of 68Ga-DOTA-SEMA in Preoperative Precise Imaging of Patients with Glucagon-Like Peptide-1 Receptor (GLP1R) Positive Insulinomas |
View |
| NCT01473940 |
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery |
View |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
View |
| NCT00365144 |
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine |
View |
